Drugs / freezedried autologous encapsulated fecal microbiota transplantation
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT07083882 | Sep 2025 → Sep 2029 expected | type 1 diabetes mellitus | Academic Medical Center - University of Amsterdam | Recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | freezedried autologous encapsulated fecal microbiota transplantation | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07083882 ↗ |
| Known as | LFMCs | “capsules containing autologous (own) lyophilized faecal microbiota, LFMCs” NCT07083882 ↗ |
| Route | Oral | “daily oral intake of autologous LFMCs” NCT07083882 ↗ |